{"created":"2023-06-20T13:45:29.040169+00:00","id":251,"links":{},"metadata":{"_buckets":{"deposit":"38cac2c9-3132-487d-8ab9-b6cb679910c2"},"_deposit":{"created_by":12,"id":"251","owners":[12],"pid":{"revision_id":0,"type":"depid","value":"251"},"status":"published"},"_oai":{"id":"oai:khsu.repo.nii.ac.jp:00000251","sets":["71"]},"author_link":["422","420","421","423","419"],"item_10007_contributor_5":{"attribute_name":"研究分担者","attribute_value_mlt":[{"contributorNames":[{"contributorName":"藤原 , 章雄"}],"nameIdentifiers":[{"nameIdentifier":"420","nameIdentifierScheme":"WEKO"}]},{"contributorNames":[{"contributorName":"大西, 紘二"}],"nameIdentifiers":[{"nameIdentifier":"421","nameIdentifierScheme":"WEKO"}]},{"contributorNames":[{"contributorName":"哈, 斯塔"}],"nameIdentifiers":[{"nameIdentifier":"422","nameIdentifierScheme":"WEKO"}]},{"contributorNames":[{"contributorName":"西東, 洋一"}],"nameIdentifiers":[{"nameIdentifier":"423","nameIdentifierScheme":"WEKO"}]}]},"item_10007_date_8":{"attribute_name":"報告年度","attribute_value_mlt":[{"subitem_date_issued_datetime":"2019","subitem_date_issued_type":"Issued"}]},"item_10007_description_10":{"attribute_name":"研究代表者番号","attribute_value_mlt":[{"subitem_description":"90155052","subitem_description_type":"Other"}]},"item_10007_description_13":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"研究成果の概要：トリプルネガティブ乳癌ではM2型腫瘍随伴マクロファージ(TAM)の浸潤と腫瘍増殖が相関し、未分化多形肉腫ではCD163陽性M2型TAMの浸潤と不良予後が相関した。マクロファージ(Mφ)と肉腫細胞との共培養で野生型に比べCD163欠損Mφで腫瘍増殖が抑制され、CD163欠損マウスでは移植肉腫の増殖が有意に抑制された。その機序としてCD163を介してMφによるIL-6産生が増強し、腫瘍増殖が促進されることを証明した。CD163の発現を抑制する天然化合物探索を行い、イカリソウ由来のepimedokoreanin BがMφと腫瘍細胞の双方でStat3活性化を抑制し、マウス移植腫瘍の増殖を抑制した。","subitem_description_type":"Abstract"}]},"item_10007_description_9":{"attribute_name":"研究課題番号","attribute_value_mlt":[{"subitem_description":"17H04060","subitem_description_type":"Other"}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2022-03-08"}],"displaytype":"detail","filename":"kaken.nii.ac.jp_17H04060seika.pdf","filesize":[{"value":"221.7 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"kaken.nii.ac.jp_17H04060seika","url":"https://khsu.repo.nii.ac.jp/record/251/files/kaken.nii.ac.jp_17H04060seika.pdf"},"version_id":"88ac2926-6929-4b21-abb7-52d0e5f245bc"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"腫瘍随伴マクロファージ","subitem_subject_scheme":"Other"},{"subitem_subject":"腫瘍微小環境","subitem_subject_scheme":"Other"},{"subitem_subject":"トリプルネガティブ乳癌","subitem_subject_scheme":"Other"},{"subitem_subject":"未分化多形肉腫","subitem_subject_scheme":"Other"},{"subitem_subject":"CD163","subitem_subject_scheme":"Other"},{"subitem_subject":"CD163欠損マウス","subitem_subject_scheme":"Other"},{"subitem_subject":"新規がん治療法","subitem_subject_scheme":"Other"},{"subitem_subject":"天然化合物","subitem_subject_scheme":"Other"},{"subitem_subject":"リンパ節洞マクロファージ","subitem_subject_scheme":"Other"},{"subitem_subject":"浸潤性膀胱癌","subitem_subject_scheme":"Other"},{"subitem_subject":"CD169","subitem_subject_scheme":"Other"},{"subitem_subject":"α1-酸性糖蛋白","subitem_subject_scheme":"Other"},{"subitem_subject":"イカリソウ","subitem_subject_scheme":"Other"},{"subitem_subject":"担癌モデルマウス","subitem_subject_scheme":"Other"},{"subitem_subject":"癌治療法開発","subitem_subject_scheme":"Other"},{"subitem_subject":"IL-6","subitem_subject_scheme":"Other"},{"subitem_subject":"がん関連線維芽細胞","subitem_subject_scheme":"Other"},{"subitem_subject":"がん治療法開発","subitem_subject_scheme":"Other"},{"subitem_subject":"CD204","subitem_subject_scheme":"Other"},{"subitem_subject":"乳癌","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_researcher":{"attribute_name":"研究代表者","attribute_type":"creator","attribute_value_mlt":[{"creatorAffiliations":[{"affiliationNameIdentifiers":[{"affiliationNameIdentifier":""}],"affiliationNames":[{"affiliationName":""}]}],"creatorNames":[{"creatorName":"竹屋, 元裕","creatorNameLang":"ja"}],"familyNames":[{}],"givenNames":[{}],"nameIdentifiers":[{}]}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"research report","resourceuri":"http://purl.org/coar/resource_type/c_18ws"}]},"item_title":"腫瘍随伴マクロファージを標的とした新規がん治療法開発のための戦略的解析","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"腫瘍随伴マクロファージを標的とした新規がん治療法開発のための戦略的解析"},{"subitem_title":"Strategic analysis for the development of new anticancer treatments targeting tumor-associated macrophages","subitem_title_language":"en"}]},"item_type_id":"10007","owner":"12","path":["71"],"pubdate":{"attribute_name":"公開日","attribute_value":"2022-03-08"},"publish_date":"2022-03-08","publish_status":"0","recid":"251","relation_version_is_last":true,"title":["腫瘍随伴マクロファージを標的とした新規がん治療法開発のための戦略的解析"],"weko_creator_id":"12","weko_shared_id":-1},"updated":"2024-04-15T07:30:07.787030+00:00"}